DOCSLIB.ORG

Regional Alcohol and Drug Detoxification Manual 2019

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Regional Alcohol and Drug Detoxification Manual 2019 Regional Alcohol and Drug Detoxification Manual 2019 Arkansas Department of Human Services Division of Aging, Adult and Behavioral Health Services Office of the Drug Director RADD Regional Alcohol and Drug Detoxification Regional Alcohol and Drug Detoxification Manual Office of the Drug Director P.O. Box 1437, Slot W-241 Little Rock, Arkansas 72203 501-686-9164 501-686-9396 (fax) 1 Regional Alcohol and Drug Detoxification Manual 2019 2 Regional Alcohol and Drug Detoxification Manual 2019 Contents Regional Alcohol and Drug Detoxification Program ......................................................................................................... 5 Chapter 1 ........................................................................................................................................................................... 7 Overview, Essential Concepts, and Definitions in Detoxification ...................................................................................... 7 Chapter 2 ......................................................................................................................................................................... 12 Settings, Levels of Care, and Patient Placement ............................................................................................................... 12 Chapter 3 ......................................................................................................................................................................... 22 An Overview of Psychosocial and Biomedical Issues During Detoxification ................................................................... 22 Chapter 4 ......................................................................................................................................................................... 35 Physical Detoxification Services for Withdrawal from Specific Substances ...................................................................... 35 Appendices ...................................................................................................................................................................... 70 Appendix A ..................................................................................................................................................................... 71 References ....................................................................................................................................................................... 71 Appendix B ..................................................................................................................................................................... 76 Common Drug Intoxication Signs and Withdrawal Symptoms ........................................................................................ 76 Appendix C ..................................................................................................................................................................... 79 Screening and Assessment Instruments ........................................................................................................................... 79 Appendix D..................................................................................................................................................................... 87 42 CFR Part 2 .................................................................................................................................................................. 87 Appendix E ................................................................................................................................................................... 117 Act 10............................................................................................................................................................................ 117 Appendix F ................................................................................................................................................................... 124 Sample forms ................................................................................................................................................................ 124 Appendix G................................................................................................................................................................... 166 List of RADD programs May 2019 ................................................................................................................................ 166 Appendix H ................................................................................................................................................................... 169 RADD Grant Document ............................................................................................................................................... 169 Appendix I .................................................................................................................................................................... 173 Program Administration Manual .................................................................................................................................... 173 Appendix J .................................................................................................................................................................... 179 Course Resources .......................................................................................................................................................... 179 3 Regional Alcohol and Drug Detoxification Manual 2019 4 Regional Alcohol and Drug Detoxification Manual 2019 Regional Alcohol and Drug Detoxification Program The primary goal of the Regional Alcohol and Drug Detoxification (RADD) program is to provide quality detoxification treatment services, while managing limited allotted resources. Meeting the unique needs of Arkansans by insuring proper and timely placement in treatment is the desired outcome of this process. The RADD manual is intended to be a guide for nurses, clinical staff, program administrators, and individuals that are involved in planning, evaluating, and providing alcohol and/or other detoxification services. All providers of RADD services will adhere to the Office of Alcohol and Drug Abuse Prevention (ADAP) rules of practice and procedure and the ADAP licensure standards for alcohol and other drug abuse treatment programs. Questions concerning the RADD program should be directed to the Arkansas Department of Human Services Division of Aging, Adult, and Behavioral Health Services Director of Treatment services or the RADD coordinator at (501) 686-9164. Questions regarding Admission and Data Management Information System (ADMIS) reporting should be directed to (501) 686-9164 as well. RADD Training Objectives (As defined in ADAP rules of practice and procedure, 2009): 1. Identify responsibilities of RADD staff • Screening applicants • Evaluating presenting symptoms • Compiling an accurate substance abuse history • Taking vital signs • Nonviolently diffusing hostile situations • Providing CPR/First Aid • Documenting any occurrence relative to the detox process 2. Identify symptoms of alcohol/drug withdrawal and implications of those symptoms 3. Learn to take vital signs and know the implications of those signs 4. Prepare participants to score 80% (or above) on written examination required to obtain certification 5 Regional Alcohol and Drug Detoxification Manual 2019 Regional Detoxification Specialist Certification (RDS) Regional Detoxification Specialists (RDS) are treatment professionals that have undergone a course of study to safely monitor clients who are in medical or observational detoxification facilities. To monitor clients in detox, you must be one of the following: Physician, Advanced Practice Registered Nurse, Registered Nurse, Licensed Practical Nurse, or RDS (Regional Detoxification Specialist). RDS Certification includes valid and up-to-date certifications in First Aid and cardiopulmonary resuscitation (CPR), Nonviolent Physical Crisis Intervention (NPCI), and RADD (Regional Alcohol Drug and Detoxification) training. If staff are not licensed medical professionals, or are without the previous trainings and certifications, they are not certified to monitor clients during the detoxification process. RDS Responsibilities: • Screening applicants • Evaluating presenting symptoms • Compiling an accurate substance abuse history • Taking vital signs • Nonviolently diffusing hostile situations • Providing CPR/First Aid • Documenting any occurrence relative to the detox process RDS must recertify every 2 years by retaking the course provided by Division of Aging, Adult, and Behavioral Health Services (DAABHS) and successfully completing the post-test with a score of 80% or better. All staff should feel comfortable taking vital signs and knowing the implications of those vital signs; evaluating signs and symptoms of withdrawal and implications of those signs and symptoms and be confident in knowledge of emergency procedures as defined in the facility policy and procedure manual. Emergency Care Plan: The program will maintain a written emergency care plan that will include the following: • At least 3 staff members trained as Regional Detoxification Specialists • The program does provide 24-hour availability of emergency services including adequate provision for handling special and difficult
Load more

Recommended publications
  • Neonatal Drug Withdrawal Abstract
    Guidance for the Clinician in Rendering Pediatric Care CLINICAL REPORT Neonatal Drug Withdrawal Mark L. Hudak, MD, Rosemarie C. Tan, MD,, PhD, THE abstract COMMITTEE ON DRUGS, and THE COMMITTEE ON FETUS AND Maternal use of certain drugs during pregnancy can result in transient NEWBORN neonatal signs consistent with withdrawal or acute toxicity or cause KEY WORDS opioid, methadone, heroin, fentanyl, benzodiazepine, cocaine, sustained signs consistent with a lasting drug effect. In addition, hos- methamphetamine, SSRI, drug withdrawal, neonate, abstinence pitalized infants who are treated with opioids or benzodiazepines to syndrome provide analgesia or sedation may be at risk for manifesting signs ABBREVIATIONS of withdrawal. This statement updates information about the clinical CNS—central nervous system — presentation of infants exposed to intrauterine drugs and the thera- DTO diluted tincture of opium ECMO—extracorporeal membrane oxygenation peutic options for treatment of withdrawal and is expanded to include FDA—Food and Drug Administration evidence-based approaches to the management of the hospitalized in- 5-HIAA—5-hydroxyindoleacetic acid fant who requires weaning from analgesics or sedatives. Pediatrics ICD-9—International Classification of Diseases, Ninth Revision — – NAS neonatal abstinence syndrome 2012;129:e540 e560 SSRI—selective serotonin reuptake inhibitor INTRODUCTION This document is copyrighted and is property of the American fi Academy of Pediatrics and its Board of Directors. All authors Use and abuse of drugs, alcohol, and tobacco contribute signi cantly have filed conflict of interest statements with the American to the health burden of society. The 2009 National Survey on Drug Use Academy of Pediatrics. Any conflicts have been resolved through and Health reported that recent (within the past month) use of illicit a process approved by the Board of Directors.
    [Show full text]
  • Drug and Alcohol Withdrawal Clinical Practice Guidelines - NSW
    Guideline Drug and Alcohol Withdrawal Clinical Practice Guidelines - NSW Summary To provide the most up-to-date knowledge and current level of best practice for the treatment of withdrawal from alcohol and other drugs such as heroin, and other opioids, benzodiazepines, cannabis and psychostimulants. Document type Guideline Document number GL2008_011 Publication date 04 July 2008 Author branch Centre for Alcohol and Other Drugs Branch contact (02) 9424 5938 Review date 18 April 2018 Policy manual Not applicable File number 04/2766 Previous reference N/A Status Active Functional group Clinical/Patient Services - Pharmaceutical, Medical Treatment Population Health - Pharmaceutical Applies to Area Health Services/Chief Executive Governed Statutory Health Corporation, Board Governed Statutory Health Corporations, Affiliated Health Organisations, Affiliated Health Organisations - Declared Distributed to Public Health System, Ministry of Health, Public Hospitals Audience All groups of health care workers;particularly prescribers of opioid treatments Secretary, NSW Health Guideline Ministry of Health, NSW 73 Miller Street North Sydney NSW 2060 Locked Mail Bag 961 North Sydney NSW 2059 Telephone (02) 9391 9000 Fax (02) 9391 9101 http://www.health.nsw.gov.au/policies/ space space Drug and Alcohol Withdrawal Clinical Practice Guidelines - NSW space Document Number GL2008_011 Publication date 04-Jul-2008 Functional Sub group Clinical/ Patient Services - Pharmaceutical Clinical/ Patient Services - Medical Treatment Population Health - Pharmaceutical
    [Show full text]
  • Substance Abuse and Dependence
    9 Substance Abuse and Dependence CHAPTER CHAPTER OUTLINE CLASSIFICATION OF SUBSTANCE-RELATED THEORETICAL PERSPECTIVES 310–316 Residential Approaches DISORDERS 291–296 Biological Perspectives Psychodynamic Approaches Substance Abuse and Dependence Learning Perspectives Behavioral Approaches Addiction and Other Forms of Compulsive Cognitive Perspectives Relapse-Prevention Training Behavior Psychodynamic Perspectives SUMMING UP 325–326 Racial and Ethnic Differences in Substance Sociocultural Perspectives Use Disorders TREATMENT OF SUBSTANCE ABUSE Pathways to Drug Dependence AND DEPENDENCE 316–325 DRUGS OF ABUSE 296–310 Biological Approaches Depressants Culturally Sensitive Treatment Stimulants of Alcoholism Hallucinogens Nonprofessional Support Groups TRUTH or FICTION T❑ F❑ Heroin accounts for more deaths “Nothing and Nobody Comes Before than any other drug. (p. 291) T❑ F❑ You cannot be psychologically My Coke” dependent on a drug without also being She had just caught me with cocaine again after I had managed to convince her that physically dependent on it. (p. 295) I hadn’t used in over a month. Of course I had been tooting (snorting) almost every T❑ F❑ More teenagers and young adults die day, but I had managed to cover my tracks a little better than usual. So she said to from alcohol-related motor vehicle accidents me that I was going to have to make a choice—either cocaine or her. Before she than from any other cause. (p. 297) finished the sentence, I knew what was coming, so I told her to think carefully about what she was going to say. It was clear to me that there wasn’t a choice. I love my T❑ F❑ It is safe to let someone who has wife, but I’m not going to choose anything over cocaine.
    [Show full text]
  • International Standards for the Treatment of Drug Use Disorders
    "*+,-.*--- -!"#$%&-'",()0"ÿ23 45 "6789!"7(@&A($!7,0B"67$!C#+D"%"*+,9779C&B"!7%EE F33"*+,-.*--- -!"#$%&-'",()0" International standards for the treatment of drug use disorders REVISED EDITION INCORPORATING RESULTS OF FIELD-TESTING International standards for the treatment of drug use disorders: revised edition incorporating results of field-testing ISBN 978-92-4-000219-7 (electronic version) ISBN 978-92-4-000220-3 (print version) © World Health Organization and United Nations Office on Drugs and Crime, 2020 Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO; https://creativecommons. org/licenses/by-nc-sa/3.0/igo). Under the terms of this license, you may copy, redistribute and adapt the work for non-commercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO or UNODC endorses any specific organization, products or services. The unauthorized use of the WHO or UNODC names or logos is not permitted. If you adapt the work, then you must license your work under the same or equivalent Creative Commons license. If you create a translation of this work, you should add the following disclaimer along with the suggested citation: “This translation was not created by the World Health Organization (WHO) or the United Nations Office on Drugs and Crime (UNODC). Neither WHO nor UNODC are responsible for the content or accuracy of this translation. The original English edition shall be the binding and authentic edition”. Any mediation relating to disputes arising under the license shall be conducted in accordance with the mediation rules of the World Intellectual Property Organization (http://www.
    [Show full text]
  • The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines
    The ICD-10 Classification of Mental and Behavioural Disorders: Clinical descriptions and diagnostic guidelines World Health Organization F10 - F19 Mental and behavioural disorders due to psychoactive substance use Overview of this block F10. – Mental and behavioural disorders due to use of alcohol F11. – Mental and behavioural disorders due to use of opioids F12. – Mental and behavioural disorders due to use of cannabinoids F13. – Mental and behavioural disorders due to use of sedative hypnotics F14. – Mental and behavioural disorders due to use of cocaine F15. – Mental and behavioural disorders due to use of other stimulants, including caffeine F16. – Mental and behavioural disorders due to use of hallucinogens F17. – Mental and behavioural disorders due to use of tobacco F18. – Mental and behavioural disorders due to use of volatile solvents F19. – Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances Four- and five-character codes may be used to specify the clinical conditions, as follows: F1x.0 Acute intoxication .00 Uncomplicated .01 With trauma or other bodily injury .02 With other medical complications .03 With delirium .04 With perceptual distortions .05 With coma .06 With convulsions .07 Pathological intoxication F1x.1 Harmful use F1x.2 Dependence syndrome .20 Currently abstinent .21 Currently abstinent, but in a protected environment .22 Currently on a clinically supervised maintenance or replacement regime [controlled dependence] .23 Currently abstinent, but receiving treatment with
    [Show full text]
  • DEMAND REDUCTION a Glossary of Terms
    UNITED NATIONS PUBLICATION Sales No. E.00.XI.9 ISBN: 92-1-148129-5 ACKNOWLEDGEMENTS This document was prepared by the: United Nations International Drug Control Programme (UNDCP), Vienna, Austria, in consultation with the Commonwealth of Health and Aged Care, Australia, and the informal international reference group. ii Contents Page Foreword . xi Demand reduction: A glossary of terms . 1 Abstinence . 1 Abuse . 1 Abuse liability . 2 Action research . 2 Addiction, addict . 2 Administration (method of) . 3 Adverse drug reaction . 4 Advice services . 4 Advocacy . 4 Agonist . 4 AIDS . 5 Al-Anon . 5 Alcohol . 5 Alcoholics Anonymous (AA) . 6 Alternatives to drug use . 6 Amfetamine . 6 Amotivational syndrome . 6 Amphetamine . 6 Amyl nitrate . 8 Analgesic . 8 iii Page Antagonist . 8 Anti-anxiety drug . 8 Antidepressant . 8 Backloading . 9 Bad trip . 9 Barbiturate . 9 Benzodiazepine . 10 Blood-borne virus . 10 Brief intervention . 11 Buprenorphine . 11 Caffeine . 12 Cannabis . 12 Chasing . 13 Cocaine . 13 Coca leaves . 14 Coca paste . 14 Cold turkey . 14 Community empowerment . 15 Co-morbidity . 15 Comprehensive Multidisciplinary Outline of Future Activities in Drug Abuse Control (CMO) . 15 Controlled substance . 15 Counselling and psychotherapy . 16 Court diversion . 16 Crash . 16 Cross-dependence . 17 Cross-tolerance . 17 Custody diversion . 17 Dance drug . 18 Decriminalization or depenalization . 18 Demand . 18 iv Page Demand reduction . 19 Dependence, dependence syndrome . 19 Dependence liability . 20 Depressant . 20 Designer drug . 20 Detoxification . 20 Diacetylmorphine/Diamorphine . 21 Diuretic . 21 Drug . 21 Drug abuse . 22 Drug abuse-related harm . 22 Drug abuse-related problem . 22 Drug policy . 23 Drug seeking . 23 Drug substitution . 23 Drug testing . 24 Drug use .
    [Show full text]
  • Alcohol Dependence, Withdrawal, and Relapse
    Alcohol Dependence, Withdrawal, and Relapse Howard C. Becker, Ph.D. Continued excessive alcohol consumption can lead to the development of dependence that is associated with a withdrawal syndrome when alcohol consumption is ceased or substantially reduced. This syndrome comprises physical signs as well as psychological symptoms that contribute to distress and psychological discomfort. For some people the fear of withdrawal symptoms may help perpetuate alcohol abuse; moreover, the presence of withdrawal symptoms may contribute to relapse after periods of abstinence. Withdrawal and relapse have been studied in both humans and animal models of alcoholism. Clinical studies demonstrated that alcohol­dependent people are more sensitive to relapse­ provoking cues and stimuli than nondependent people, and similar observations have been made in animal models of alcohol dependence, withdrawal, and relapse. One factor contributing to relapse is withdrawal­related anxiety, which likely reflects adaptive changes in the brain in response to continued alcohol exposure. These changes affect, for example, the body’s stress response system. The relationship between withdrawal, stress, and relapse also has implications for the treatment of alcoholic patients. Interestingly, animals with a history of alcohol dependence are more sensitive to certain medications that impact relapse­like behavior than animals without such a history, suggesting that it may be possible to develop medications that specifically target excessive, uncontrollable alcohol consumption. KEY WORDS: Alcoholism; alcohol dependence; alcohol and other drug (AOD) effects and consequences; neuroadaptation; AOD withdrawal syndrome; AOD dependence relapse; pharmacotherapy; human studies; animal studies he development of alcohol expectations about the consequences of drinking (Koob and Le Moal 2008). dependence is a complex and alcohol use.
    [Show full text]
  • 2019 Lezlie Murch, Hilary Aquino, Ronald Mccray
    DAVID L. MURPHY SOBERING CENTER A COLLABORATION BETWEEN EXODUS RECOVERY AND LOS ANGLES COUNTY DEPARTMENT OF HEALTH SERVICES 2019 Lezlie Murch, Hilary Aquino, Ronald McCray by Unknown Author is licensed under SOBERING MODEL • A safe and supportive environment where an intoxicated person can be observed while recovering from active and acute inebriation 2 Exodus Sobering Center Mission (focused on Skid Row and adjacent) The Mission of the Sobering Center is to reduce incarcerations, minimize hospitalizations and assist active, chronic and serial inebriates living on and around Skid Row by providing a path to recovery in a safe and welcoming environment. 3 Sobering Center versus Detox Center A Sobering Center is a different model than a detoxification/ inpatient or residential facility Comparison DLM/ Exodus Sobering Center Detox/Residential Alcohol . Clients must be brought in by designated referral and Other Drug Treatment sources (law enforcement, homeless outreach teams, mental health providers, Exodus staff, local ED’s, . Clients can self refer community partners) . Average length of stay is a minimum of 72 hours . Average length of stay is nine (9) hours and up to several months in step down care . Clients rest in a “sobering pod” in a group setting Clients are assigned a room and private bed/area . Clients are offered hydration and light snacks Full meals are served . Clients must be assessed as medically stable to admit Clients are generally medically unstable and require 24 hour medical observation . Clients under nursing/staff observation who follow . prescribed medical protocols Clients are given detox medication for withdrawal symptoms . Clients are engaged in recovery dialogue by Sober .
    [Show full text]
  • Within-Subjects Analyses of 2-Year Alcohol Trajectories
    RESEARCH AND PRACTICE Project-Based Housing First for Chronically Homeless Individuals With Alcohol Problems: Within-Subjects Analyses of 2-Year Alcohol Trajectories Susan E. Collins, PhD, Daniel K. Malone, MPH, Seema L. Clifasefi, PhD, Joshua A. Ginzler, PhD, Michelle D. Garner, MSW, PhD, Bonnie Burlingham, MPH, Heather S. Lonczak, PhD, Elizabeth A. Dana, MA, Megan Kirouac, BS, Kenneth Tanzer, BA, William G. Hobson, MA, G. Alan Marlatt, PhD, and Mary E. Larimer, PhD A review of 29 studies conducted worldwide Objectives. Two-year alcohol use trajectories were documented among estimated an alcohol dependence prevalence of residents in a project-based Housing First program. Project-based Housing First 1 37.9% among homeless populations. Among provides immediate, low-barrier, nonabstinence-based, permanent supportive chronically homeless individuals (i.e., people with housing to chronically homeless individuals within a single housing project. The long-term, often-repeated episodes of homeless- study aim was to address concerns that nonabstinence-based housing may ness2), the prevalence of alcohol dependence enable alcohol use. is even higher.3 Alcohol dependence is associ- Methods. A 2-year, within-subjects analysis was conducted among 95 chron- ated with greater levels of alcohol problems, ically homeless individuals with alcohol problems who were allocated to project- resulting from acute intoxication or long-term based Housing First. Alcohol variables were assessed through self-report. Data on intervention exposure were extracted from agency records. alcoholuse,aswellasincreasedriskforalcohol- Results. Multilevel growth models indicated significant within-subjects de- related deaths.4 --- 7 creases across alcohol use outcomes over the study period. Intervention Unfortunately, traditional housing infra- exposure, represented by months spent in housing, consistently predicted structures designed to serve chronically additional decreases in alcohol use outcomes.
    [Show full text]
  • Download Drink: a Cultural History of Alcohol Free Ebook
    DRINK: A CULTURAL HISTORY OF ALCOHOL DOWNLOAD FREE BOOK Iain Gately | 546 pages | 05 May 2009 | GOTHAM BOOKS | 9781592404643 | English | New York, United States A History of Hooch Chesterton, Orthodoxy A substance that a third of the world institutionalizes as a religious sacrament and another third expressly forbids on religious grounds is one to be reckoned with. This is linked to faster Drink: A Cultural History of Alcohol of consumption, and can lead to tension and possibly violence as patrons attempt to manoevre around each other. Alcohol and its effects have been present in societies throughout history. Log in or link your magazine subscription. It's why people grew crops, it's why they went to war, and it's why they put so much hops in the Easily one of my favorite books of all time. Unlike binge drinking, its focus is on competition or the establishment of a record. Guinness World Records edition, p. No trivia or quizzes yet. I liked the continuity of the narrative, connecting the world across thousands Drink: A Cultural History of Alcohol years. Drys vs. Your drink is not being taken from you. They were, however, limited to an allowance of eight pints per day. Then prohibit This is one remarkably well-researched, well-written, and fascinating book. Spirits are good, wine is bad. Booze has presided over executions and business deals and marriages and births. It is widely observed that in areas of Europe where children and adolescents routinely consume alcohol early and with parental approval, binge drinking tends to be less prevalent.
    [Show full text]
  • Cuyahoga County Opioid Use Disorder Information & Resource
    Cuyahoga County Opioid Use Disorder Information & Resource Guide Developed by the MetroHealth Office of Opioid Safety’s First Responders Project 815588MH_Booklet.indd 1 9/25/18 7:42 AM Table of Contents What is Opioid Use Disorder .................................................. 1 Assessments ............................................................................. 1 TREATMENT Treatment Overview ............................................................... 2 Counseling ............................................................................. 3 Opioid Withdrawal .............................................................. 3 Medication Assisted Treatment – How Does it Work? ................................................................. 4 - Buprenorphine Medication Assisted Treatment - Methadone Medication Assisted Treatment - Naltrexone Medication Assisted Treatment Inpatient Treatment .................................................................. 6 Outpatient Treatment ................................................................ 6 RECOVERY Recovery Housing .................................................................. 7 Recovery Support Groups ...................................................... 7 PROGRAMS AND SERVICES Harm Reduction ..................................................................... 8 Project DAWN .......................................................................... 8 Naloxone in Pharmacies with a Prescription .......................... 9 Syringe Exchange Program ..................................................
    [Show full text]
  • DEPARTMENT of FAMILY and COMMUNITY MEDICINE 2019 Annual Report MESSAGE from the CHAIR
    DEPARTMENT OF FAMILY AND COMMUNITY MEDICINE 2019 Annual Report MESSAGE FROM THE CHAIR Over the past year, the Department of Family and Community Medicine at Baylor College of Medicine continued its work at the forefront of medical education and discovery to deliver excellent and holistic patient care. I am pleased that as part of U.S. News & World Report rankings for the best medical schools in the U.S., Baylor College of Medicine ranked #4 in Primary Care Programs and #13 in Family Medicine Specialties. I fully concur with the President, CEO and Executive Dean of Baylor College of Medicine, Paul Klotman, M.D., FACP, who wrote in making the announcement, “The consistent high ranking is a clear indication of our strength and the combined efforts of our faculty, staff, and trainees. The tremendous support we have from our Board of Trustees, affiliated hospitals, community partners and alumni is also an important factor in Baylor College of Medicine continuing to be the highest ranked medical school in Texas as well as the Southwest region.” An April 25 ribbon cutting marked the official opening of the Baylor Medicine Family Medicine Clinic in Houston’s River Oaks area. I joined James T. McDeavitt, M.D., the Senior Vice President and Dean of Clinical Affairs, and President Klotman, who officiated the festivities. The new 8,000 square foot facility has 14 exam rooms, onsite labs, and diagnostics, with same-day and next-day appointments available. Our department now provides holistic care for the entire family at three full-service clinic locations. Other successes filled FY2019 as well.
    [Show full text]